Abstract-The time course of alterations in coagulative and fiblinolytic activities was studied in CC14-induced liver disease in mice. Liver disease was induced by administration of 20% CC14 in olive oil (p.o.). After single administration of CC14, significant prolongation of r and k values and decrease in the ma value of thrombo elastogram and apparent prolongation of PT and PTT were seen at 24 hr. Fibrinogen content decreased from 12 to 72 hr after single administration, while a mild but significant decrease in fibrinogen was observed after multiple adminis trations.
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The activity of factor XI II increased from 5 to 12 hr and then decreased from 24 to 168 hr after single administration.
The activity of the hepaplastintest and Antithrombin III decreased apparently after single and multiple administrations. The plasminogen content and the activity of a2-plasmin inhibitor decreased severely after single and multiple administrations.
These results indicate that the coagulative and fibrinolytic activities were decreased to the most lowest value at 24 or 48 hr after single administration of CC14, and the severe suppression of fibrinolysis and the mild decrease in coagulative activity were observed after multiple administrations of CC14. The reason for the different effects between single and multiple administrations on coagulative and fibrinolytic systems was discussed.
Oral administration of carbon tetrachloride (CC14) to animals leads to parenchymal cell injuries including centrilobular necrosis of the liver (1) . In our previous studies (2), we reported that CC14 administration in mice induced severe liver damage with abnormal values in blood components and with the depression of reticuloendothelial system (RES). Many factors of the coagulative and fibrinolytic systems are synthesized by the liver. In fact, Shaw has confirmed the functional capacity of the isolated liver for synthesizing proteins and vitamin K dependent coagulation factors (3); and patients with liver disease often exhibit multiple coagulation defects (4, 5) . Therefore, CC14 treatment is considered to induce the decrease in the activity of many factors of the coagulative and fibrinolytic systems, because the metabolic activation of CC14 is associated with the formation in the endoplasmic reticulum of free radicals which interact with cell constituents (6) . However, experimental studies on the changes in the coagulative and fibrinolytic activities
have not yet been reported, especially using mice. The clotting time is dependent on numerous factors including temperature, water quality, pH, ionic strength, test system and anticoagulant used and the technique for specimen collection. These factors seemed to make it more difficult to investigate the activity of coagulation and fibrinolysis in mice. If the basic data on the activity of coagulation and fibrinolysis are obtained using mice with liver injury, it will be to our benefit when we examine the effect of various kinds of therapeutic agents for liver disease. Because mice are so small, easy to handle and very cheap, it is convenient for us to use them for this experimental model. Therefore, it is important to know the time course of coagulative and fibrinolytic activities in acute and chronic liver injury induced by CC14 administrations.
The purpose of this paper is to examine the alterations in blood coagula tive and fiblinolytic activities in mice after single and multiple administrations of CC14.
Materials and Methods Animal and drug administration
Male ddy mice, 5 weeks of age at the start of experiment, were fed with a stock diet (MF, Oriental Kobo Co. Ltd.) and tap water ad libitum under standard laboratory con ditions. The mice were divided into three groups: saline control group, olive oil treated group and CC14 treated group, in acute and chronic liver injury experiments, respectively. CC14 and olive oil were purchased from Wako pure chemical industries, Ltd. Each animal received 0.2 ml of 20% CC14 in olive oil (CC14: 0.04 ml) by stomach tubes to induce acute liver damage. The control group received 0.2 ml of olive oil or 0.9% NaCI solution per mouse. To induce chronic liver damage, 0.04 ml CC14 per mouse was given to animals 3 times a week (every other day) for 5 weeks, that is, the total number of 0.04 ml CC14 injections were 15. We examined all items of the experiment at 5, 12, 24, 48, 72 and 120 hr after single administration and 48 hr after multiple administrations. Blood collection and preparation Blood specimens were taken from the vena cava inferior with a plastic syringe and silicon-coated needle after pentobarbital anaesthesia (nembutal, 40 mg/kg, i.p.). Citrated plasma was prepared as follows: whole blood from mice was mixed with 3.2% sodium citrate solution at the ratio of nine to one, and then it was centrifuged at 3,000 r.p.rn. for 15 min at 4°C. The supernatant was used for the specimen as platelet-poor plasma. We used whole blood to determine thromboelastogram (TEG Results TEG: Figure 2 shows the typical TEG figures with time course after single injection of CCI4. Manifest changes in figures were not seen at 5 and 12 hr, but abnormal patterns were observed with severe inhibition of coagulation or with abnormal enhancement of fibrinolysis at 24 hr. TEG figures 48, 72 and 120 hr after CCI4 injection showed gradual recovering tendencies, and at 168 hr, they were almost the same as that of the control. On the other hand, multiple treatments of CCI4 produced different TEG figures, making it impossible to pinpoint one typical figure of TEG as a result of multiple treatments of CCI4. Figure 3 shows the r, k and ma values of TEG after single and multiple treatments of CCI4.
Here we see that the r value of the control was about 8 min and that it increased about 1.7 times that of the olive oil and/or control values at 24 hr after single administration of CCI4. However, the increasing tendency of the r value continued up to 48 hr after CCI4 treatment.
The k value of the control was about 2.5 min and increased dramatically 24 hr after single treatment of CCI4. At 168 hr after single injection of CCI4, the k value recovered to the normal range. The ma value of the control was about 68 mm, and that of CCI4 24 hr after single administration decreased to half in comparison to that of control. It gradually recovered to the normal range and showed the same value compared to that before injection of CCI4. On the other hand, no significant effects were observed after multiple treatments of CCI4 because of the variability of r, k and ma values.
PT and PTT: Figure 4 shows the time course of PT and PTT following CCI4 adminis tration. After single treatment of olive oil, PT shortened at 5, 72 and 120 hr. At 5 hr after single administration of CCI4, PT was short; however, at 12 and 24 hr, CCI4 injection caused a significant elongation compared to saline and olive oil treated mice. On the other hand, PTT shortened significantly at 12 hr after olive oil treatment. It become longer for Each value represents the mean value with S.D. ** ,*: significant difference from the saline control value with P<0.01, P<0.05.%, significant difference from the olive oil control value with P<0.01, P<0.05 (Student's t-test). Therefore, multiple administrations of CCI4 was seen to decrease the activity of factor XIII compared to that of the olive oil control.
AT III: As shown in Fig. 7 , the activity of AT III decreased from 12 to 72 hr after single administration of CCI4. They were For details, see Fig. 3 . y .: significant difference from the olive oil control value with P<0.01, P<0.05 (Student's t-test).
For details, see Fig. 3 . 'x: significant differ ence from the olive oil control value with P< 0.01 (Student's t-test).
For details, see Fig. 3 . Fig. 9 . Effect of single and multiple administrations of CCI, on plasminogen content. Plasminogen contents are shown in ratio compared to that of normal human plasma. **,*: significant difference from the saline control value with P<0.01, P<0.05. ttz: significant difference from the olive oil control value with P<0.01 (Student's t-test).
For details, see Fig. 3 . Fig. 10 . Effect of single and multiple administrations of CCI4 on the activity of a2-plasmin inhibitor. a2-plasmin inhibitor activities are shown as a ratio compared to that of normal human plasma. **,*: significant difference from the saline control value with P<0.01, P<0.05. "0: significant difference from the olive oil control value with P<0.01 (Student's t-test).
For details, see Fig. 3 . (4, 5) . However, there have been only a very few reports on the changes in these systems using experimental animals other than rabbits (12) and rats (13, 14) . In order to know the degree of acute and chronic liver damage, the time course of coagulative and fibrinolytic activities following single and multiple administrations of CCI4 was examined using mice. Our results with mice show that after a single administration of CCI4, whole blood coagula tive and fibrinolytic factors begin to be sup pressed at 12 hr, and this becomes drastic at 24 and 48 hr. Especially, the concentration of fibrinogen, activity of factor XIII, PLG level and a2-PI activity continued to show very low values up to 72 hr. After multiple administrations of CCI4, coagulative factors showed a mild but evident depression to about 60-85% that of the saline control. On the other hand, fibrinolytic factors, PLG and a2-PI showed a more severe decrease to about 47-55% that of the saline control.
PT is sensitive to deficiencies in the extrinsic coagulation system, that is, factor II, V, VII and X. The normal PT range for mice at our laboratory lies between 7.5 and 8.6 sec. PTT is sensitive to deficiencies in the intrinsic system, that is, factors II, V, VIII, IX, X, XI and XII. The normal PTT range for mice lies between 45 and 47 sec. In our results, olive oil treatment caused a shortening of PT and PTT, and a drastic prolongation of PT (31.4 sec) and PTT (66.1 sec) was observed 24 hr after single adminis tration of CCI4, whereas no significant prolongation at 48 hr was observed because of the wide variety of dIl the values. In this experimental liver disease by CCI4, the intrinsic coagulation system was abnormal at just only 24 hr after single administration, and no change was seen after multiple ones. On the other hand, the abnormality of the extrinsic coagulation system continued from 12 to 72 hr after single administration.
A mild elongation was observed in comparison to olive oil after multiple ones. Therefore, CCI4 seemed to induce the deficiencies of extrinsic coagulation factors rather more strongly than those of intrinsic factors. In other animal experiments using CCI4, in this case rabbits, the prolongation of PT and PTT was also observed with the decrease in fibrinogen content 24 hr after single adminis tration (12) .
TEG is a very convienient method to find out the entire mobilization of coagulative and fibrinolytic activity. At 24 hr after single administration of CCI4, abnormal patterns of TEG figures, inhibition of coagulation and enhancement of fibrinolysis were observed. Concerning r, k and ma values after single administration of CCI4, a severe elongation of the r value at 24 hr and the long-term elongation of k value were observed. The r value contributed to thromboplastin for mation time and the 1< value was equivalent to thrombin formation time. Therefore, single administration of CCI4 was considered to cause the strong inhibition of thrombin formation.
The ma value indicated the strength of the clot, that is, the platelet numbers and function and fibrinogen content could be judged from it. Our results showed the ma value decreasing drastically at 24 hr and then recovering to the normal range at 120 hr after single administration of CC14. These results showed that changes of the ma value was related to fibrinogen content after single administration of CCI4. While, no change in the ma value after multiple adminis trations of CCI4 was observed, although fibrinogen content showed mild but sig nificant decrease. Weston et al. (15) has previously reported that platelets reduced in numbers and were smaller than those of healthy controls in 34 patients with fulminant hepatic failure. Therefore, it is important to examine platelet numbers and function after single and multiple injections, and this is now under study in our laboratory.
Fibrinogen is synthesized largely or exclusively in the liver, as demonstrated in the isolated perfused rat liver (3) and in hepatic slices (16) . The site of synthesis has been localized to the parenchymal cells (17) . In experimental liver disease using rabbits (12) and rats (13, 14) , an apparent decrease in fibrinogen content was observed 24 hr after single injection of CCI4, as in our data using mice. The turnover rate of fibrinogen is known to be 23-41 hr in rats (18), compared to 60-90 hr in humans, but it is not known in mice. Our results showed a decrease in fibrinogen content up to 72 hr after single administration of CCI4 (0.04 ml/body). If the turnover rate of fibrinogen in mice is the same as the one in rats, the continued decrease in fibrinogen up to 72 hr is considered a consistent result .
Factor XIII is important in the cross linking of fibrin monomers. It is also said that it is a fibrin stabilizing factor (FSF). Factor XIII decreases in the case of disseminated intravascular coagulation syndrome (DIC). The decrease in factor XIII is possibly due to (a) consumption to crosslink fibrin monomer, (b) absorption on the fibrin clot, and (c) destruction by the serine proteases (19) . The concentration of factor XIII is decreased in the plasma of some patients with hepatic disease (21) (22) . Whether the deficiency of factor XIII in hepatic disease is due to failure of synthesis is not known. Our results showed that the activity of factor XIII was enhanced at 5 and 12 hr after single administration of CC14. However, it is difficult to distinguish the effect between CC14 and olive oil, because the apparent increase in factor XIII activity was observed 5 hr after single administration of olive oil. At 24 hr, this activity decreased drastically, and its long-term decrease continued up to 168 hr after single administration of CC14. One of the reasons for this decrease is the consumption to crosslink fibrin monomer, since the fibrinogen content decreased ap parently up to 72 hr and recovered to the normal range at 120 hr after single adminis tration of CC14. Conceivably, in this case with the decrease in factor XIII, formed fibrin clots are more susceptible to fibrinolysis than is normal fibrin.
It was recognized that two proteins, a2 macroglobulin and AT III, were responsible for the progressive inactivation of thrombin. Also, the activity of AT III is undoubtedly considered to reflect the damage of the liver cells where AT III is synthesized.
Clinically, the concentration of AT III diminishes in patients with chronic hepatic disease. From our results, CC14 induced liver injury caused an apparent decrease in AT III activity after single and multiple administrations of CC14. In addition, HPT, which determines the true activity of coagulation factors (11, VII and X), was decreased after single and multiple administrations of CC14. This means that the depression of the productive ability of these factors in liver cells was actual.
Lysis of fibrin is brought about by a proteolytic enzyme, plasmin. PLG is con verted to plasmin enzymatically by kinase or activators found in plasma (plasma activator), in urine (urokinase), in the tissues (tissue activator), and in body secretions. In humans, monkeys and dogs, streptokinase activates plasma PLG; while in rabbits and rats, urokinases activates it (23). In our experiments, longer incubation time was necessary for activating plasma PLG in mice than in rats. Natural inhibitors of fibrinolysis inhibit the activation of PLG already formed (24) . Since the affinity of a2-PI for plasmin is far greater than that of other inhibitors, this inhibitor is considered the most im portant in the regulation of fibrinolysis. From our results, a severe decrease in PLG content and a2-PI activity was observed up to 72 hr after single administration and 48 hr after multiple ones of CC14. Especially, multiple administrations of CC14 seemed to cause a more drastic inhibition of the fibrinolytic system than the coagulative system. These results are considered as one of the causes of a more mild decrease in the coagulative system after multiple administrations of CC14 than after single administration.
The reticuloendothelial system (RES) is important in removing clotting products from circulating blood. It is well-known that RE cells play an important role in the removal of intravascular fibrin (25). RES blockade by thorotrast or trypan blue increases the sensitivity of rabbits to the generalized Shwartzman reaction (26). In a previous study (2) , a significant decrease in RES function with a more mild change of bio chemical parameters was observed after multiple injections of CC14 than after single injection. In this paper, a mild but significant decrease in fibrinogen content, AT Ill and H PT activity was reported after multiple administrations of CC14. The decrease in coagulative factors was attributable to the decrease in the synthesizing activity of the parenchymal cells because of liver damage by CC14. However, high dosage of CC14 after a single treatment does not show high toxicity for cells because of the decrease in CC13 formation in rats (27), and Busuttil et al. (28) reported that biochemical manifestation of hepatic injury during the development of cirrhosis was prominent only in cases of acute injury from intermittent doses in rats. Our results in the coagulative system also seemed to show a more apparent change in liver injury by a single treatment of CC14 than that by multiple treatments. Sugai et al. (29) postulated that hyperproduction of coagula tive factors might be induced by the regeneration of liver cells after inflammation or by the inflammatory stimulation on hepatic parenchymal cells. In the previous paper, we showed severe steatosis and necrotic inflammation in chronic liver injury after multiple administrations of CC14 (2) . There fore, we can also postulate that these multiple administrations of CC14 induce the hyperproduction of coagulative factors. On the other hand, the activities of the fibrinolytic system, PLG and a2 PI, were suppressed severely after multiple treatments of CC14. This severe decrease in PLG and a2 PI might be due to the consumptive decrease by activation of fibrinolysis except the decrease in synthesizing activity of the liver cells, because in multiple administrations of CC14 during 5 weeks, necrotic hepatocytes are considerd to activate clotting factors within the circulating plasma.
In these experimental conditions using mice, the decrease in coagulative and fibrinolytic factors seemed to reflect accurately liver cell injury induced by single adminis tration of CC14, while multiple adminis trations of CC14 might induce the hyper production of coagulative factors and the complex counterbalance during he coagula tive and fibrinolytic systems. However, it is important to know the situation of both systems in chronic liver injury using experi mental animals. Therefore, the present experimental model using mice is useful for studying the effect of therapeutic agents for liver disease.
